Pharmacolog signs distribution agreement with SmartCompounders B.V.
Pharmacolog AB has entered into an agreement with the company SmartCompounders B.V., Enschede, the Netherlands, regarding the sale, distribution and marketing of DrugLog® in the Netherlands.
The agreement means that Pharmacolog will have a partner with a presence in and extensive experience in sales and service of medical device equipment in the Dutch market. SmartCompunders B.V. are focusing their sales activities towards hospital pharmacies and is particularly strong in the field of chemotherapy. SmartCompounding B.V. has also developed a completely new type of compounding robot that they market to hospital pharmacies and larger drug compunding centers.
Mats Högberg, CEO, comments: “We are very pleased to take this important strategic step in our European market expansion. The Netherlands is an important market as it is well advanced in technology and is quick to adopt new solutions. SmartCompounders, under the lead of Sander Van Vreeland, is an excellent partner to us with long experience of working towards hospital pharmacies. We are now hoping, with the help of Sanders team, to be able to transform the interest we have seen in DrugLog® into real orders.”
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.